Kala Pharmaceuticals Inc. (KALA) NASDAQ

$0.70 -0.04 (-5.58%)

Market Cap: $50.74M

As of 05/18/22 04:00 PM EDT. Market closed.

(KALA)

Kala Pharmaceuticals Inc. (KALA) NASDAQ

$0.70 -0.04 (-5.58%)

Market Cap: $50.74M

As of 05/18/22 04:00 PM EDT. Market closed.

Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry ... read more

Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of pre-clinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Mark Iwicki
Full Time Employees
188
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
URL
Address
490 Arsenal Way, Suite 120, Massachusetts, Watertown, 02472.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Mark Iwicki
Full Time Employees
188
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
Address
490 Arsenal Way, Suite 120, Massachusetts, Watertown, 02472.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$0.74
Days Range
$0.65 - $0.75
52 week range
$0.59 - $6.77
Volume
0
Avg. Volume (30 days)
756,878
Market Cap
$50.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
72,594,005
Open
$0
Previous Close
$0.74
Days Range
$0.65 - $0.75
52 week range
$0.59 - $6.77
Volume
0
Avg. Volume (30 days)
756,878
Market Cap
$50.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
72,594,005

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KALA PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Reumuth Mary CHIEF FINANCIAL OFFICER Jan 04, 2022 Sale $1.30 2,850 3,705 133,208 Jan 05, 2022, 08:00 PM
Brazzell Romulus K SEE REMARKS Jan 04, 2022 Sale $1.30 3,504 4,555 288,345 Jan 05, 2022, 08:00 PM
Bazemore Todd SEE REMARKS Jan 04, 2022 Sale $1.30 3,454 4,490 118,591 Jan 05, 2022, 08:00 PM
Iwicki Mark T CHIEF EXECUTIVE OFFICER Jan 04, 2022 Sale $1.30 9,518 12,373 259,158 Jan 05, 2022, 08:00 PM
Trachtenberg Eric SEE REMARKS Jan 04, 2022 Sale $1.30 2,850 3,705 113,816 Jan 05, 2022, 08:00 PM
Chen Hongming CHIEF SCIENTIFIC OFFICER Oct 26, 2021 Sale $1.80 9,449 17,008 225,566 Oct 28, 2021, 08:06 PM
Chen Hongming CHIEF SCIENTIFIC OFFICER Oct 27, 2021 Sale $1.82 21,051 38,313 204,515 Oct 28, 2021, 08:06 PM
Trachtenberg Eric SEE REMARKS Oct 26, 2021 Sale $1.80 9,449 17,008 116,666 Oct 28, 2021, 08:05 PM
Reumuth Mary CHIEF FINANCIAL OFFICER Oct 26, 2021 Sale $1.80 9,449 17,008 136,058 Oct 28, 2021, 08:04 PM
Bazemore Todd CHIEF OPERATING OFFICER Oct 26, 2021 Sale $1.80 12,544 22,579 122,045 Oct 28, 2021, 08:03 PM
Brazzell Romulus K CHIEF MEDICAL OFFICER Oct 26, 2021 Sale $1.80 12,757 22,963 291,849 Oct 28, 2021, 08:02 PM
Iwicki Mark T CHIEF EXECUTIVE OFFICER Oct 26, 2021 Sale $1.80 27,598 49,676 268,676 Oct 28, 2021, 08:01 PM
Chen Hongming CHIEF SCIENTIFIC OFFICER Jun 29, 2021 Sale $5.56 5,548 30,847 235,015 Jun 30, 2021, 05:30 PM
Chen Hongming CHIEF SCIENTIFIC OFFICER Jun 28, 2021 Sale $5.77 2,452 14,148 240,563 Jun 29, 2021, 05:26 PM
Brazzell Romulus K CHIEF MEDICAL OFFICER Jun 28, 2021 Sale $5.77 3,034 17,506 300,962 Jun 29, 2021, 05:26 PM
Trachtenberg Eric SEE REMARKS Jun 28, 2021 Sale $5.77 2,452 14,148 126,115 Jun 29, 2021, 05:26 PM
Reumuth Mary CHIEF FINANCIAL OFFICER Jun 28, 2021 Sale $5.77 2,452 14,148 145,507 Jun 29, 2021, 05:26 PM
Bazemore Todd CHIEF OPERATING OFFICER Jun 28, 2021 Sale $5.77 2,911 16,796 134,589 Jun 29, 2021, 05:25 PM
Iwicki Mark T CHIEF EXECUTIVE OFFICER Jun 28, 2021 Sale $5.77 7,586 43,771 296,274 Jun 29, 2021, 05:25 PM
Chen Hongming Chief Scientific Officer Mar 01, 2021 Option Exercise $2.30 9,500 21,850 243,015 Mar 03, 2021, 12:00 AM
Chen Hongming Chief Scientific Officer Feb 25, 2021 Option Exercise $2.30 47,000 108,100 233,515 Feb 26, 2021, 05:35 PM
Bazemore Todd Chief Operating Officer Jun 05, 2020 Buy $13.39 2 27 2 Oct 28, 2020, 08:36 PM
Bazemore Todd Chief Operating Officer Oct 22, 2020 Buy $7.60 40 304 42 Oct 28, 2020, 08:36 PM
Rosen Howard B Director Aug 19, 2019 Option Exercise $0.60 4,824 2,872 4,824 Jun 29, 2020, 09:54 PM
Trachtenberg Eric See Remarks Jun 19, 2020 Option Exercise $5.19 28,901 149,996 28,901 Jun 22, 2020, 04:06 PM
Reumuth Mary Chief Financial Officer Jun 09, 2020 Option Exercise $2.64 43,477 114,771 48,293 Jun 11, 2020, 04:58 PM
Brazzell Romulus K Chief Medical Officer Apr 09, 2020 Option Exercise $2.99 67,771 202,377 176,496 Apr 13, 2020, 08:38 AM
Chen Hongming Chief Scientific Officer Mar 30, 2020 Option Exercise $2.30 31,000 71,300 86,849 Apr 01, 2020, 04:43 PM
Bazemore Todd Chief Operating Officer Mar 16, 2020 Buy $5.75 10,000 57,500 10,000 Mar 17, 2020, 05:46 PM
Grunberg Gregory Director Mar 13, 2020 Buy $7.89 2,534,854 19,999,998 2,534,854 Mar 16, 2020, 07:59 AM
Shah Rajeev M. Director Mar 13, 2020 Buy $7.89 6,337,135 49,999,994 10,874,613 Mar 13, 2020, 06:47 PM
RA CAPITAL MANAGEMENT, L.P. Director Mar 13, 2020 Buy $7.89 6,337,135 49,999,994 10,874,613 Mar 13, 2020, 06:45 PM
Rosen Howard B Director May 30, 2019 Buy $5.42 5,000 27,100 8,240 Jun 03, 2019, 10:41 AM
Grunberg Gregory Director Oct 05, 2018 Buy $8.25 606,060 4,999,995 2,877,006 Oct 09, 2018, 04:46 PM
Shah Rajeev M. Director Oct 03, 2018 Buy $8.25 2,424,242 19,999,997 4,537,478 Oct 05, 2018, 04:34 PM
RA CAPITAL MANAGEMENT, LLC Director Oct 03, 2018 Buy $8.25 2,424,242 19,999,997 4,537,478 Oct 05, 2018, 04:33 PM
Chen Hongming Chief Scientific Officer Feb 28, 2018 Option Exercise $2.26 9,769 22,123 55,849 Mar 02, 2018, 05:19 PM
ORBIMED ADVISORS LLC 10% Owner Feb 08, 2018 Buy $12.93 25,000 323,250 3,447,840 Feb 12, 2018, 04:35 PM
ORBIMED ADVISORS LLC 10% Owner Feb 02, 2018 Buy $14.73 37,840 557,383 3,422,840 Feb 06, 2018, 05:05 PM
ORBIMED ADVISORS LLC 10% Owner Feb 01, 2018 Buy $14.99 22,840 342,372 3,385,000 Feb 02, 2018, 05:45 PM
ORBIMED ADVISORS LLC 10% Owner Jan 31, 2018 Buy $15.00 339,400 5,091,000 3,362,160 Feb 02, 2018, 05:45 PM
ORBIMED ADVISORS LLC 10% Owner Jan 29, 2018 Buy $14.99 50,000 749,500 3,022,760 Jan 30, 2018, 03:34 PM
ORBIMED ADVISORS LLC 10% Owner Jan 26, 2018 Buy $14.93 22,760 339,807 2,972,760 Jan 30, 2018, 03:34 PM
ORBIMED ADVISORS LLC 10% Owner Jan 24, 2018 Buy $14.91 64,637 963,738 2,950,000 Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC 10% Owner Jan 23, 2018 Buy $14.99 4,363 65,401 2,885,363 Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC 10% Owner Jan 22, 2018 Buy $14.98 75,000 1,123,500 2,881,000 Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC 10% Owner Jan 19, 2018 Buy $14.95 74,931 1,120,218 2,806,000 Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC 10% Owner Jan 12, 2018 Buy $14.50 38,354 556,133 2,731,069 Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC 10% Owner Jan 11, 2018 Buy $13.65 41,700 569,205 2,664,269 Jan 12, 2018, 05:29 PM
ORBIMED ADVISORS LLC 10% Owner Jan 10, 2018 Buy $12.83 170,338 2,185,437 2,622,569 Jan 12, 2018, 05:29 PM
ORBIMED ADVISORS LLC 10% Owner Jan 12, 2018 Buy $15.40 28,446 438,068 2,692,715 Jan 12, 2018, 05:29 PM
Brazzell Romulus K Chief Medical Officer Aug 11, 2017 Option Exercise $1.64 108,725 178,039 108,725 Aug 15, 2017, 04:08 PM
ORBIMED ADVISORS LLC 10% Owner Jul 25, 2017 Buy $15.00 319,333 4,789,995 2,375,279 Jul 27, 2017, 07:17 PM
Longitude Capital Partners II, LLC 10% Owner Jul 25, 2017 Buy $15.00 215,000 3,225,000 2,270,946 Jul 27, 2017, 05:23 PM
RA CAPITAL MANAGEMENT, LLC Director Jul 25, 2017 Buy $15.00 533,333 7,999,995 2,113,236 Jul 26, 2017, 04:44 PM
Grunberg Gregory Director Jul 25, 2017 Buy $15.00 215,000 3,225,000 2,270,946 Jul 26, 2017, 04:31 PM
Shah Rajeev M. Director Jul 25, 2017 Buy $15.00 533,333 7,999,995 2,113,236 Jul 26, 2017, 04:31 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 20, 2017 Buy $15.00 215,000 3,225,000 763,755 Jul 21, 2017, 05:54 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 20, 2017 Buy $15.00 215,000 3,225,000 763,755 Jul 21, 2017, 03:58 PM
CDK ASSOCIATES, L.L.C. 10% Owner Jul 20, 2017 Buy $15.00 215,000 3,225,000 215,000 Jul 20, 2017, 06:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Reumuth Mary CHIEF FINANCIAL OFFICER 01/04/2022 3,705
Brazzell Romulus K SEE REMARKS 01/04/2022 4,555
Bazemore Todd SEE REMARKS 01/04/2022 4,490
Iwicki Mark T CHIEF EXECUTIVE OFFICER 01/04/2022 12,373
Trachtenberg Eric SEE REMARKS 01/04/2022 3,705
Chen Hongming CHIEF SCIENTIFIC OFFICER 10/26/2021 17,008
Chen Hongming CHIEF SCIENTIFIC OFFICER 10/27/2021 38,313
Trachtenberg Eric SEE REMARKS 10/26/2021 17,008
Reumuth Mary CHIEF FINANCIAL OFFICER 10/26/2021 17,008
Bazemore Todd CHIEF OPERATING OFFICER 10/26/2021 22,579
Brazzell Romulus K CHIEF MEDICAL OFFICER 10/26/2021 22,963
Iwicki Mark T CHIEF EXECUTIVE OFFICER 10/26/2021 49,676
Chen Hongming CHIEF SCIENTIFIC OFFICER 06/29/2021 30,847
Chen Hongming CHIEF SCIENTIFIC OFFICER 06/28/2021 14,148
Brazzell Romulus K CHIEF MEDICAL OFFICER 06/28/2021 17,506
Trachtenberg Eric SEE REMARKS 06/28/2021 14,148
Reumuth Mary CHIEF FINANCIAL OFFICER 06/28/2021 14,148
Bazemore Todd CHIEF OPERATING OFFICER 06/28/2021 16,796
Iwicki Mark T CHIEF EXECUTIVE OFFICER 06/28/2021 43,771
Chen Hongming Chief Scientific Officer 03/01/2021 21,850
Chen Hongming Chief Scientific Officer 02/25/2021 108,100
Bazemore Todd Chief Operating Officer 06/05/2020 27
Bazemore Todd Chief Operating Officer 10/22/2020 304
Rosen Howard B Director 08/19/2019 2,872
Trachtenberg Eric See Remarks 06/19/2020 149,996
Reumuth Mary Chief Financial Officer 06/09/2020 114,771
Brazzell Romulus K Chief Medical Officer 04/09/2020 202,377
Chen Hongming Chief Scientific Officer 03/30/2020 71,300
Bazemore Todd Chief Operating Officer 03/16/2020 57,500
Grunberg Gregory Director 03/13/2020 19,999,998
Shah Rajeev M. Director 03/13/2020 49,999,994
RA CAPITAL MANAGEMENT, L.P. Director 03/13/2020 49,999,994
Rosen Howard B Director 05/30/2019 27,100
Grunberg Gregory Director 10/05/2018 4,999,995
Shah Rajeev M. Director 10/03/2018 19,999,997
RA CAPITAL MANAGEMENT, LLC Director 10/03/2018 19,999,997
Chen Hongming Chief Scientific Officer 02/28/2018 22,123
ORBIMED ADVISORS LLC 10% Owner 02/08/2018 323,250
ORBIMED ADVISORS LLC 10% Owner 02/02/2018 557,383
ORBIMED ADVISORS LLC 10% Owner 02/01/2018 342,372
ORBIMED ADVISORS LLC 10% Owner 01/31/2018 5,091,000
ORBIMED ADVISORS LLC 10% Owner 01/29/2018 749,500
ORBIMED ADVISORS LLC 10% Owner 01/26/2018 339,807
ORBIMED ADVISORS LLC 10% Owner 01/24/2018 963,738
ORBIMED ADVISORS LLC 10% Owner 01/23/2018 65,401
ORBIMED ADVISORS LLC 10% Owner 01/22/2018 1,123,500
ORBIMED ADVISORS LLC 10% Owner 01/19/2018 1,120,218
ORBIMED ADVISORS LLC 10% Owner 01/12/2018 556,133
ORBIMED ADVISORS LLC 10% Owner 01/11/2018 569,205
ORBIMED ADVISORS LLC 10% Owner 01/10/2018 2,185,437
ORBIMED ADVISORS LLC 10% Owner 01/12/2018 438,068
Brazzell Romulus K Chief Medical Officer 08/11/2017 178,039
ORBIMED ADVISORS LLC 10% Owner 07/25/2017 4,789,995
Longitude Capital Partners II, LLC 10% Owner 07/25/2017 3,225,000
RA CAPITAL MANAGEMENT, LLC Director 07/25/2017 7,999,995
Grunberg Gregory Director 07/25/2017 3,225,000
Shah Rajeev M. Director 07/25/2017 7,999,995
CDK ASSOCIATES, L.L.C. 10% Owner 07/20/2017 3,225,000
CDK ASSOCIATES, L.L.C. 10% Owner 07/20/2017 3,225,000
CDK ASSOCIATES, L.L.C. 10% Owner 07/20/2017 3,225,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
03/31/2021
5.75%
3Q
12/31/2021
12/31/2020
24.49%
4Q
12/31/2021
06/30/2020
35.18%
6Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
5.75%
3Q
12/31/2020
24.49%
4Q
06/30/2020
35.18%
6Q